|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| C07K 14/605 |
| (11) | Number of the document | 3129041 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15713772.0 |
| Date of filing the European patent application | 2015-04-07 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/057442 |
| Date | 2015-04-07 |
| (87) | Number | WO 2015/155151 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 14163697 | 2014-04-07 | EP |
| (72) |
LINDEROTH, Lars, DK
KOFOED, Jacob, DK
LAU, Jesper, DK
BLOCH, Paw, DK
GARIBAY, Patrick William, DK
KODRA, Jįnos Tibor, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | DOUBLE-ACYLATED GLP-1 COMPOUNDS |
| DOUBLE-ACYLATED GLP-1 COMPOUNDS |